Scarica l'app Stockscreener
21.30
4.26%
0.87
Dopo l'orario di chiusura:
21.30
Precedente Chiudi:
$20.43
Aprire:
$20.68
Volume 24 ore:
7.18M
Relative Volume:
1.34
Capitalizzazione di mercato:
$10.58B
Reddito:
$4.45B
Utile/perdita netta:
$205.00M
Rapporto P/E:
53.25
EPS:
0.4
Flusso di cassa netto:
$372.00M
1 W Prestazione:
-3.97%
1M Prestazione:
-4.36%
6M Prestazione:
+48.95%
1 anno Prestazione:
+71.50%
Intervallo 1D:
$20.50
$21.30
Intervallo di 1 settimana:
$20.41
$22.19
Portata 52W:
$8.02
$23.70
Elanco Animal Health Inc Stock (ELAN) Company Profile
Nome
Elanco Animal Health Inc
Settore
Telefono
877-352-6261
Indirizzo
450 ELANCO CIRCLE, INDIANAPOLIS
Confronta ELAN con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ELAN
Elanco Animal Health Inc
|
21.30 | 10.15B | 4.45B | 205.00M | 372.00M | 0.40 |
|
ZTS
Zoetis Inc
|
118.07 | 51.01B | 9.40B | 2.65B | 2.24B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.37 | 45.05B | 29.63B | 260.53M | 5.51B | 0.0788 |
|
HLN
Haleon Plc Adr
|
9.46 | 41.46B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
29.80 | 32.77B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
484.86 | 20.51B | 3.08B | 1.24B | 1.07B | 25.61 |
Elanco Animal Health Inc Stock (ELAN) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-11-21 | Iniziato | KeyBanc Capital Markets | Overweight |
| 2025-11-19 | Aggiornamento | Argus | Hold → Buy |
| 2025-10-07 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2025-07-17 | Aggiornamento | Leerink Partners | Market Perform → Outperform |
| 2025-06-26 | Aggiornamento | William Blair | Mkt Perform → Outperform |
| 2024-12-09 | Iniziato | UBS | Buy |
| 2024-12-02 | Iniziato | Leerink Partners | Market Perform |
| 2024-09-19 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2024-01-05 | Aggiornamento | Stifel | Hold → Buy |
| 2023-12-19 | Iniziato | Jefferies | Buy |
| 2023-12-15 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2023-12-07 | Iniziato | Exane BNP Paribas | Outperform |
| 2023-04-20 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2022-08-18 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2022-08-16 | Downgrade | JP Morgan | Overweight → Neutral |
| 2022-07-21 | Downgrade | Goldman | Buy → Sell |
| 2022-07-12 | Iniziato | Piper Sandler | Neutral |
| 2021-11-18 | Iniziato | Morgan Stanley | Overweight |
| 2021-10-28 | Downgrade | Stifel | Buy → Hold |
| 2021-08-05 | Ripresa | Credit Suisse | Outperform |
| 2021-06-15 | Aggiornamento | Cleveland Research | Underperform → Neutral |
| 2021-05-11 | Aggiornamento | Barclays | Underweight → Equal Weight |
| 2021-05-11 | Aggiornamento | Gabelli & Co | Hold → Buy |
| 2021-04-15 | Iniziato | Stifel | Buy |
| 2021-03-22 | Downgrade | Gabelli & Co | Buy → Hold |
| 2021-02-26 | Aggiornamento | Credit Suisse | Neutral → Outperform |
| 2020-12-09 | Downgrade | Argus | Buy → Hold |
| 2020-11-09 | Downgrade | Barclays | Overweight → Underweight |
| 2020-08-20 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2020-08-13 | Ripresa | Credit Suisse | Neutral |
| 2020-08-04 | Ripresa | Goldman | Buy |
| 2020-07-27 | Downgrade | Cleveland Research | Neutral → Underperform |
| 2020-04-02 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2020-01-10 | Iniziato | Raymond James | Mkt Perform |
| 2019-12-19 | Aggiornamento | BofA/Merrill | Neutral → Buy |
| 2019-11-07 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2019-09-23 | Iniziato | Barclays | Overweight |
| 2019-08-26 | Downgrade | BofA/Merrill | Buy → Neutral |
| 2019-08-15 | Aggiornamento | UBS | Sell → Neutral |
| 2019-05-23 | Iniziato | Guggenheim | Neutral |
| 2019-03-18 | Aggiornamento | BofA/Merrill | Neutral → Buy |
| 2019-03-13 | Ripresa | Morgan Stanley | Equal-Weight |
| 2019-02-12 | Iniziato | William Blair | Mkt Perform |
| 2019-01-23 | Iniziato | UBS | Sell |
| 2019-01-15 | Iniziato | Argus | Buy |
| 2018-10-15 | Iniziato | Morgan Stanley | Equal-Weight |
Mostra tutto
Elanco Animal Health Inc Borsa (ELAN) Ultime notizie
Elanco Animal Health: Strategic Dual Channel Focus and Robust Innovation Pipeline Drive Buy Rating - TipRanks
Elanco Invests $400 Million in Indiana to Expand U.S. R&D and Manufacturing Operations - Southeast AgNET
How Protein And Pets Drove This Stock's Double-Digit Advance - Investor's Business Daily
Elanco (ELAN) Announces Major Cost-Cutting Initiative - GuruFocus
Barclays Initiates Coverage on Elanco Animal Health (ELAN) with Overweight Rating | ELAN Stock News - GuruFocus
Elanco Animal Health Incorporated Announces Organizational Changes - marketscreener.com
Elanco Animal Health (NYSE:ELAN) Coverage Initiated by Analysts at Barclays - MarketBeat
Elanco Animal Health Incorporated Announces Continued Investment in Its U.S. Operations, Workforce and Communities over the Next Five Years - marketscreener.com
Elanco (ELAN) Outlines Promising Financial Projections for 2026 Onward - GuruFocus
Elanco Investor Day Defines New Era as Sustainable Growth Company - PR Newswire
Norges Bank Purchases New Shares in Elanco Animal Health Incorporated $ELAN - MarketBeat
Elanco Animal Health Incorporated $ELAN Shares Acquired by Hsbc Holdings PLC - MarketBeat
What downside risks could hit Elanco Animal Health Incorporated stockJuly 2025 PostEarnings & Fast Entry Momentum Trade Alerts - Newser
Will Elanco Animal Health Incorporated (5EA) stock outperform benchmarksOptions Play & Long-Term Investment Growth Plans - Newser
Why retail traders accumulate Elanco Animal Health Incorporated stockQuarterly Trade Summary & Weekly Watchlist for Consistent Profits - Newser
Why institutional investors increase stakes in Elanco Animal Health Incorporated stockWeekly Trend Summary & Free Expert Approved Momentum Trade Ideas - Newser
ELAN SEC FilingsElanco Animal Health 10-K, 10-Q, 8-K Forms - Stock Titan
Channing Capital Management LLC Decreases Position in Elanco Animal Health Incorporated $ELAN - MarketBeat
Aquatic Veterinary Market Set to See Booming Growth 2025-2032 - openPR.com
Is Elanco Animal Health Incorporated stock vulnerable to rate hikesTrade Analysis Summary & Capital Efficiency Focused Strategies - Newser
SG Americas Securities LLC Sells 70,517 Shares of Elanco Animal Health Incorporated $ELAN - MarketBeat
Will Elanco Animal Health Incorporated stock beat international competitionMarket Trend Review & Expert-Curated Trade Recommendations - Newser
Elanco Animal Health (NYSE: ELAN) reports 10,314-share equity grant to director - Stock Titan
Elanco (ELAN) director reports 10,314-share deferred stock unit award - Stock Titan
Elanco (NYSE: ELAN) director R. David Hoover reports 10,314-share board equity award - Stock Titan
Elanco (ELAN) board director receives 10,314 deferred stock units in annual grant - Stock Titan
Elanco Animal Health (ELAN) director reports 10,314-share deferred stock grant - Stock Titan
Elanco (ELAN) director awarded 10,314 deferred stock units in Form 4 filing - Stock Titan
Can Elanco Animal Health Incorporated (5EA) stock retain market dominance - Newser
Legal & General Group Plc Boosts Stake in Elanco Animal Health Incorporated $ELAN - MarketBeat
Elanco Animal Health Incorporated $ELAN Position Raised by Brandes Investment Partners LP - MarketBeat
Can Elanco Animal Health Incorporated (5EA) stock deliver consistent EPS growthJuly 2025 Action & Momentum Based Trading Ideas - Newser
Will Elanco Animal Health Incorporated (5EA) stock boost dividends furtherTake Profit & Low Drawdown Investment Ideas - Newser
Is Elanco Animal Health Incorporated stock vulnerable to regulatory risksLong Setup & Weekly Watchlist of Top Performers - Newser
mRNA Vaccines for Animals Market Forecast 2025-2032: Emerging - openPR.com
Creative Planning Increases Stock Position in Elanco Animal Health Incorporated $ELAN - MarketBeat
Elanco Animal Health (NYSE:ELAN) Stock Steady on Sector Review - Kalkine Media
Elanco Animal Health Incorporated (NYSE:ELAN) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat
Ensign Peak Advisors Inc Cuts Stake in Elanco Animal Health Incorporated $ELAN - MarketBeat
Elanco Animal Health (ELAN) Is Up 8.6% After FDA Clears First Cat Screwworm Treatment – Has the Bull Case Changed? - Yahoo Finance
Can Elanco Animal Health Incorporated stock beat market expectations this quarterJuly 2025 Update & Free Low Drawdown Momentum Trade Ideas - BỘ NỘI VỤ
Rockefeller Capital Management L.P. Purchases 13,893 Shares of Elanco Animal Health Incorporated $ELAN - MarketBeat
Aug Decliners: Is Elanco Animal Health Incorporated stock dividend yield sustainableIPO Watch & High Return Trade Guides - BỘ NỘI VỤ
Elanco Animal Health Announces $245M Stock-For-Stock Acquisition Of Aratana Therapeutics - AOL.com
Elanco executive appointed as Neurizon’s board observer By Investing.com - Investing.com Canada
Elanco executive appointed as Neurizon's Board Observer - Yahoo Finance
Prudential Financial Inc. Sells 1,773,395 Shares of Elanco Animal Health Incorporated $ELAN - MarketBeat
Elanco, AMN Healthcare Services, Brookdale, DexCom, and Addus HomeCare Shares Skyrocket, What You Need To Know - Finviz
Top Animal Health Stocks: Elanco Leads with Innovation, Zoetis Faces Headwinds - Investing.com Canada
Analysts Set Expectations for ELAN FY2025 Earnings - MarketBeat
Director Harrington Michael J bought $51,974 worth of shares (3,500 units at $14.85), increasing direct ownership by 5% to 81,094 units (SEC Form 4) - Quantisnow
Elanco Animal Health Inc Azioni (ELAN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.29%
4.87%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):